These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 15218389)

  • 1. Implantable cardioverter-defibrillators: expanding indications.
    Naccarelli GV
    Curr Opin Cardiol; 2004 Jul; 19(4):317-22. PubMed ID: 15218389
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Implantable cardioverter-defibrillators: expanding indications and technologies.
    Goldberger Z; Lampert R
    JAMA; 2006 Feb; 295(7):809-18. PubMed ID: 16478904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications.
    Crespo EM; Kim J; Selzman KA
    Am J Med Sci; 2005 May; 329(5):238-46. PubMed ID: 15894866
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of Inappropriate Shocks and Other Health Outcomes Between Single- and Dual-Chamber Implantable Cardioverter-Defibrillators for Primary Prevention of Sudden Cardiac Death: Results From the Cardiovascular Research Network Longitudinal Study of Implantable Cardioverter-Defibrillators.
    Peterson PN; Greenlee RT; Go AS; Magid DJ; Cassidy-Bushrow A; Garcia-Montilla R; Glenn KA; Gurwitz JH; Hammill SC; Hayes J; Kadish A; Reynolds K; Sharma P; Smith DH; Varosy PD; Vidaillet H; Zeng CX; Normand ST; Masoudi FA
    J Am Heart Assoc; 2017 Nov; 6(11):. PubMed ID: 29122811
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Implantable Cardioverter Defibrillators for Primary Prevention of Mortality in Patients With Nonischemic Cardiomyopathy: A Meta-Analysis of Randomized Controlled Trials.
    Stavrakis S; Asad Z; Reynolds D
    J Cardiovasc Electrophysiol; 2017 Jun; 28(6):659-665. PubMed ID: 28316104
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Implantable cardioverter defibrillators in primary and secondary prevention: a systematic review of randomized, controlled trials.
    Ezekowitz JA; Armstrong PW; McAlister FA
    Ann Intern Med; 2003 Mar; 138(6):445-52. PubMed ID: 12639076
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effectiveness of implantable cardioverter-defibrillators for the primary prevention of sudden cardiac death in women with advanced heart failure: a meta-analysis of randomized controlled trials.
    Ghanbari H; Dalloul G; Hasan R; Daccarett M; Saba S; David S; Machado C
    Arch Intern Med; 2009 Sep; 169(16):1500-6. PubMed ID: 19752408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Primary Prevention Implantable Cardioverter Defibrillators in Patients With Nonischemic Cardiomyopathy: A Meta-analysis.
    Al-Khatib SM; Fonarow GC; Joglar JA; Inoue LYT; Mark DB; Lee KL; Kadish A; Bardy G; Sanders GD
    JAMA Cardiol; 2017 Jun; 2(6):685-688. PubMed ID: 28355432
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deactivation of implantable cardioverter-defibrillators: results of patient surveys.
    Herman D; Stros P; Curila K; Kebza V; Osmancik P
    Europace; 2013 Jul; 15(7):963-9. PubMed ID: 23447573
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Non-ischaemic cardiomyopathy, sudden death and implantable defibrillators: a review and meta-analysis.
    Beggs SAS; Jhund PS; Jackson CE; McMurray JJV; Gardner RS
    Heart; 2018 Jan; 104(2):144-150. PubMed ID: 28986406
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sudden cardiac death: New approaches for implantable cardioverter-defibrillators (ICDs).
    Cappato R; Ali H
    Int J Cardiol; 2017 Jun; 237():38-41. PubMed ID: 28377192
    [TBL] [Abstract][Full Text] [Related]  

  • 12. What risk should justify implantable cardioverter defibrillator therapy?
    Schläpfer J; Kappenberger L; Fromer M
    Am J Cardiol; 1999 Mar; 83(5B):101D-103D. PubMed ID: 10089850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Implantable cardioverter-defibrillators for primary prevention: how do the data pertain to the aged?
    Daubert JP; Sesselberg HW; Huang DT
    Am J Geriatr Cardiol; 2006; 15(2):88-92. PubMed ID: 16525221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of transvenous implantable cardioverter-defibrillators in preventing sudden cardiac death in children, adolescents, and young adults.
    Chatrath R; Porter CB; Ackerman MJ
    Mayo Clin Proc; 2002 Mar; 77(3):226-31. PubMed ID: 11888025
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Implantable defibrillators versus medical therapy for cardiac channelopathies.
    McNamara DA; Goldberger JJ; Berendsen MA; Huffman MD
    Cochrane Database Syst Rev; 2015 Oct; 2015(10):CD011168. PubMed ID: 26445202
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Primary prevention of sudden cardiac death using implantable cardioverter defibrillators.
    Ding L; Hua W; Niu H; Chen K; Zhang S
    Europace; 2008 Sep; 10(9):1034-41. PubMed ID: 18559335
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prevention of sudden cardiac death: from wearable to subcutaneous cardioverter defibrillator.
    Viani S; Soldati E; DI Cori A; Segreti L; Paperini L; DE Lucia R; Zucchelli G; Bongiorni MG
    Minerva Cardioangiol; 2018 Feb; 66(1):83-99. PubMed ID: 28696089
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effectiveness of implantable cardioverter defibrillators for primary prevention of sudden cardiac death in subgroups a systematic review.
    Earley A; Persson R; Garlitski AC; Balk EM; Uhlig K
    Ann Intern Med; 2014 Jan; 160(2):111-21. PubMed ID: 24592496
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Implantable cardioverter/defibrillators for primary prevention in dilated cardiomyopathy post-DANISH: an updated meta-analysis and systematic review of randomized controlled trials.
    Wolff G; Lin Y; Karathanos A; Brockmeyer M; Wolters S; Nowak B; Fürnkranz A; Makimoto H; Kelm M; Schulze V
    Clin Res Cardiol; 2017 Jul; 106(7):501-513. PubMed ID: 28213711
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The impact of gender on survival amongst patients with implantable cardioverter defibrillators for primary prevention against sudden cardiac death.
    Henyan NN; White CM; Gillespie EL; Smith K; Coleman CI; Kluger J
    J Intern Med; 2006 Nov; 260(5):467-73. PubMed ID: 17040253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.